When Kelly Knee was in graduate school in the early 2000s, she found it nearly impossible to secure grant funding for research on sickle cell disease, a rare blood disorder that historically has been a neglected area of medical research. But hearing stories from patients, who suffer severe pain...
If you check the labels on your favorite jarred marinara sauce, low-calorie salad dressing, or loaf of bread, you may be surprised to find that they contain added simple sugars — one of the most popular forms of which is high-fructose corn syrup (HFCS), a sweetener used in many processed...
In the battle against COVID-19, big data has been critical to nearly every aspect of the global response: from tracking the spread of the virus and understanding the course of the disease to coordinating supply of personal protective equipment (PPE) and ventilators in hospitals. ...
Researchers and scientists around the world are working to develop a potential COVID-19 vaccine. Given the urgency of the pandemic, different groups are using different methods. ...
Whenever a patient takes a drug and has an unexpected side effect — from minor problems like a runny nose to more serious ones that require hospitalization — pharma companies are legally required to report this information, known as an adverse event (AE), to regulatory agencies. ...
As scientists around the globe race to find ways to treat COVID-19, the fastest approach to finding a treatment may be to repurpose existing drugs in the hopes of avoiding having to start from “square one” on the drug development pathway. There are dozens of existing drugs currently being...
The current global scale of the COVID-19 pandemic requires nothing short of a fast-moving and nimble international effort to thwart it. ...
As early as ancient Greece, doctors used a method called palpation to diagnose illness, pressing their hands on a patient’s abdomen to assess the firmness of diseased tissues and organs. ...
With the rise of precision medicine, scientists are hopeful that more cancer patients can receive treatments tailored to their specific tumor mutations. But with these advances, a matchmaking problem has also emerged: It can be very challenging to recruit enough patients with specific tumor...